Paper28670710
Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery.
Juthani VV and 2 others. Cochrane Database Syst Rev, 2017. Cited by 98 papers, by iCite.
Cite this record
ConductScience Library. Non-steroidal anti-inflammatory drugs versus corticosteroids for controlling inflammation after uncomplicated cataract surgery. Papers, record 28670710. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28670710
- Disease
- Pain508 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenal Cortex Hormones | Major topic |
| Anti-Inflammatory Agents, Non-Steroidal | Major topic |
| Cataract Extraction | Major topic |
| Eye Diseases | Major topic |
| Phacoemulsification | Major topic |
| Postoperative Complications | Major topic |
| Corneal Edema | |
| Drug Therapy, Combination | |
| Humans | |
| Inflammation | |
| Macular Edema | |
| Randomized Controlled Trials as Topic | |
| Visual Acuity |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| U01 EY020522 | NEI NIH HHS | United States | U01EY020522 | PubMed and NIH |
Source NIH RePORTER
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT04200651 | Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery | Background | ClinicalTrials.gov | |
| NCT04246801 | Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1) | Results | ClinicalTrials.gov | |
| NCT04249076 | Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2) | Results | ClinicalTrials.gov |
References95
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7990331 | [Influence of steroidal and nonsteroidal anti-inflammatory drugs on post-operative blood-aqueous barrier in pseudophakia]. | Klin Oczna | 1994 | https://conductscience.org/library/papers/7990331 | PubMed |
| 2 | 27885591 | The Impact of Non-Steroidal Anti-Inflammatory Agents after Phacoemulsification on Quality of Life: A Randomized Study. | Ophthalmol Ther | 2017 | https://conductscience.org/library/papers/27885591 | PubMed |
| 3 | 12678152 | Comparison of topical prednisolone acetate, ketorolac tromethamine and fluorometholone acetate in reducing inflammation after phacoemulsification. | J Med Assoc Thai | 2003 | https://conductscience.org/library/papers/12678152 | PubMed |
| 4 | 11320025 | Keratitis, ulceration, and perforation associated with topical nonsteroidal anti-inflammatory drugs. | Ophthalmology | 2001 | https://conductscience.org/library/papers/11320025 | PubMed |
| 5 | 2666532 | Prospective, randomized trial of oral piroxicam in the prophylaxis of postoperative cystoid macular edema. | J Ocul Pharmacol | 1989 | https://conductscience.org/library/papers/2666532 | PubMed |
| 6 | 12446370 | Effects of dexamethasone, diclofenac, or placebo on the inflammatory response after cataract surgery. | Br J Ophthalmol | 2002 | https://conductscience.org/library/papers/12446370 | PubMed |
| 7 | 27388251 | Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy. | Br J Ophthalmol | 2017 | https://conductscience.org/library/papers/27388251 | PubMed |
| 8 | 24935281 | Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. | Ophthalmology | 2014 | https://conductscience.org/library/papers/24935281 | PubMed |
| 9 | 9279674 | Effectiveness of diclofenac eyedrops in reducing inflammation and the incidence of cystoid macular edema after cataract surgery. | J Cataract Refract Surg | 1996 | https://conductscience.org/library/papers/9279674 | PubMed |
| 10 | 25385061 | Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study. | Br J Ophthalmol | 2015 | https://conductscience.org/library/papers/25385061 | PubMed |
| 11 | 26107761 | Treatment Paradigm After Uncomplicated Cataract Surgery: A Prospective Evaluation. | Asia Pac J Ophthalmol (Phila) | 2014 | https://conductscience.org/library/papers/26107761 | PubMed |
| 12 | 4555322 | Topical corticosteroids after cataract surgery. | Ann Ophthalmol | 1972 | https://conductscience.org/library/papers/4555322 | PubMed |
| 13 | 16196117 | Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. | Am J Ophthalmol | 2005 | https://conductscience.org/library/papers/16196117 | PubMed |
| 14 | 16931258 | Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve. | J Cataract Refract Surg | 2006 | https://conductscience.org/library/papers/16931258 | PubMed |
| 15 | 18165082 | Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0.1% and betamethasone 0.1%. | J Cataract Refract Surg | 2008 | https://conductscience.org/library/papers/18165082 | PubMed |
| 16 | 11095120 | Ketorolac-tobramycin combination vs fluorometholone-tobramycin combination in reducing inflammation following phacoemulsification cataract extraction with scleral tunnel incision. | Ophthalmic Surg Lasers | 2000 | https://conductscience.org/library/papers/11095120 | PubMed |
| 17 | 27920490 | A randomized double-masked study to compare the ocular safety, tolerability, and efficacy of bromfenac 0.075% compared with vehicle in cataract surgery subjects. | Clin Ophthalmol | 2016 | https://conductscience.org/library/papers/27920490 | PubMed |
| 18 | 26232601 | Prevention of Cystoid Macular Edema After Cataract Surgery in Nondiabetic and Diabetic Patients: A Systematic Review and Meta-Analysis. | Am J Ophthalmol | 2015 | https://conductscience.org/library/papers/26232601 | PubMed |
| 19 | 19728943 | Comparison of anti-inflammatory activity of dexamethasone and diclofenac sodium eye drops in phacoemulsification. | J Coll Physicians Surg Pak | 2009 | https://conductscience.org/library/papers/19728943 | PubMed |
| 20 | 15078665 | Prevalence of cataract and pseudophakia/aphakia among adults in the United States. | Arch Ophthalmol | 2004 | https://conductscience.org/library/papers/15078665 | PubMed |
Cited by55
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 98 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42299442 | Subfoveal Choroidal Thickness in Clinically Significant Pseudophakic Cystoid Macular Edema: An Interocular Comparison with Contralateral Pseudophakic Eyes. | Clin Ophthalmol | 2026 | https://conductscience.org/library/papers/42299442 | PubMed |
| 42192627 | Efficacy and safety of clobetasol propionate ophthalmic nanoemulsion for treating intraocular inflammation and pain associated with cataract surgery: two phase 3 multicentre, randomised, placebo-controlled, double-masked clinical studies. | BMJ Open | 2026 | https://conductscience.org/library/papers/42192627 | PubMed |
| 42146064 | Culture supernatants from human-derived commensal bacteria alleviate DNCB-induced atopic dermatitis through modulation of inflammatory and barrier-associated pathways. | Front Microbiol | 2026 | https://conductscience.org/library/papers/42146064 | PubMed |
| 41210954 | Comparison of Ahmed Glaucoma Valve Implantation Alone Versus Combined with Phacoemulsification in Chinese Primary Open-Angle Glaucoma. | Clin Ophthalmol | 2025 | https://conductscience.org/library/papers/41210954 | PubMed |
| 40416177 | Steroid-Responsive Intraocular Lens Deposits: A Case-Based Review of Diagnosis and Management. | Cureus | 2025 | https://conductscience.org/library/papers/40416177 | PubMed |
| 40150009 | Incidence, Pathogenesis, Risk Factors, and Treatment of Cystoid Macula Oedema Following Cataract Surgery: A Systematic Review. | Diagnostics (Basel) | 2025 | https://conductscience.org/library/papers/40150009 | PubMed |
| 39525715 | Clobetasol propionate for post-cataract surgery pain and inflammation. | Ann Med Surg (Lond) | 2024 | https://conductscience.org/library/papers/39525715 | PubMed |
| 39095467 | Topical NSAIDs impact on macular oedema and visual outcome after phacoemulsification: systematic review of RCTs with network meta-analysis. | Eye (Lond) | 2024 | https://conductscience.org/library/papers/39095467 | PubMed |
| 39022042 | Effect of surface-modified intraocular lenses on long-term postoperative inhibition of posterior capsule opacification. | Heliyon | 2024 | https://conductscience.org/library/papers/39022042 | PubMed |
| 38435373 | A Preservative-Free Approach - Effects on Dry Eye Signs and Symptoms After Cataract Surgery. | Clin Ophthalmol | 2024 | https://conductscience.org/library/papers/38435373 | PubMed |
| 38362131 | Effects of Soy Bread on Cardiovascular Risk Factor, Inflammation and Oxidative Stress in Women With Active Rheumatoid Arthritis: A Randomized Double-Blind Controlled Trial. | Clin Nutr Res | 2024 | https://conductscience.org/library/papers/38362131 | PubMed |
| 37895903 | Treatments for Ocular Diseases in Pregnancy and Breastfeeding: A Narrative Review. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/37895903 | PubMed |
| 37827217 | The Neuropeptide α-Melanocyte-Stimulating Hormone Prevents Persistent Corneal Edema following Injury. | Am J Pathol | 2024 | https://conductscience.org/library/papers/37827217 | PubMed |
| 37723594 | Pseudophakic macular edema in nondiabetic and diabetic patients without diabetic retinopathy treated with intravitreal dexamethasone implant. | Int J Retina Vitreous | 2023 | https://conductscience.org/library/papers/37723594 | PubMed |
| 37639162 | Schinus terebinthifolius Raddi (Brazilian pepper) leaves extract: in vitro and in vivo evidence of anti-inflammatory and antioxidant properties. | Inflammopharmacology | 2023 | https://conductscience.org/library/papers/37639162 | PubMed |
| 37123408 | The double-edged sword of inflammation in inherited retinal degenerations: Clinical and preclinical evidence for mechanistically and prognostically impactful but treatable complications. | Front Cell Dev Biol | 2023 | https://conductscience.org/library/papers/37123408 | PubMed |
| 36979695 | Computational and Preclinical Analysis of 2-(4-Methyl)benzylidene-4,7-dimethyl Indan-1-one (IPX-18): A Novel Arylidene Indanone Small Molecule with Anti-Inflammatory Activity via NF-κB and Nrf2 Signaling. | Biomedicines | 2023 | https://conductscience.org/library/papers/36979695 | PubMed |
| 36902768 | Should Multifocal Intraocular Lenses Become a Standard in Phacoemulsification Cataract Surgery? | J Clin Med | 2023 | https://conductscience.org/library/papers/36902768 | PubMed |
| 36673054 | Changes in Macular Thickness after Cataract Surgery in Patients with Open Angle Glaucoma. | Diagnostics (Basel) | 2023 | https://conductscience.org/library/papers/36673054 | PubMed |
| 36602718 | Early Inflammation Control After Trabeculectomy by Steroid and Non-steroidal Eye Drops: A Randomized Controlled Trial. | Ophthalmol Ther | 2023 | https://conductscience.org/library/papers/36602718 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AHR | 196 | PubTator's text mining | https://conductscience.org/library/genes/196 | NCBI Gene |
| COX8A | 1351 | PubTator's text mining | https://conductscience.org/library/genes/1351 | NCBI Gene |
| MT-CO2 | 4513 | PubTator's text mining | https://conductscience.org/library/genes/4513 | NCBI Gene |
| PLA2G1B | 5319 | PubTator's text mining | https://conductscience.org/library/genes/5319 | NCBI Gene |
| PTGS2 | 5743 | PubTator's text mining | https://conductscience.org/library/genes/5743 | NCBI Gene |
| VEGFA | 7422 | PubTator's text mining | https://conductscience.org/library/genes/7422 | NCBI Gene |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| CLOBETASOL PROPIONATE | CHEMBL1159650 | Results | 2 | https://conductscience.org/library/drugs/CHEMBL1159650 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28670710
GET https://conductscience.org/api/papers/v1/28670710/references?page=2